Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment.
Robert A HauserAntonella FavitL Arthur HewittAnnika LindstenStephen GornySteven KymesStuart H IsaacsonPublished in: Neurology and therapy (2022)
NCT02586623.